CAS 1047645-82-8

GSK2110183B

CAS : 1047645-82-8

Formule : C₁₈H₁₈Cl₃FN₄OS

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 463.7841

Ref: IN-DA008TDB

Afuresertib hydrochloride

CAS : 1047645-82-8

Afuresertib hydrochloride

Degré de pureté : ≥98%

Masse moléculaire : 463.8g/mol

Ref: 54-BUP09723

Afuresertib hydrochloride

CAS : 1047645-82-8

Afuresertib hydrochloride is an inhibitor of Akt kinase (Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively)

Formule : C₁₈H₁₈Cl₃FN₄OS

Degré de pureté : 99.96%

Couleur et forme : Solid

Masse moléculaire : 463.8

Ref: TM-T7885

2-THIOPHENECARBOXAMIDE, N-[(1S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL]-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-, HCL (1:1)

CAS : 1047645-82-8

Degré de pureté : 98+%

Masse moléculaire : 463.7799988

Ref: 10-F857573

Afuresertib hydrochloride

CAS : 1047645-82-8

Afuresertib hydrochloride is a small-molecule inhibitor, which is synthesized as a targeted therapeutic agent. It is specifically designed to inhibit the activity of AKT kinase, a crucial component in the PI3K/AKT/mTOR signaling pathway. This pathway is frequently deregulated in various cancers, contributing to tumor growth, survival, and resistance to conventional therapies.

Formule : C₁₈H₁₈Cl₃FN₄OS

Degré de pureté : Min. 95%

Masse moléculaire : 463.78 g/mol

Ref: 3D-XRB64582